Combination Drugs
-
{
- All
- News
- Videos
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Combining These Two Commonly Prescribed Drugs May Reverse Fatty Liver, Reveals Study
Pemafibrate and Telmisartan are medications primarily used to manage cholesterol and blood pressure, respectively. The study suggests that they may also be highly effective when used together to treat fatty liver disease.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Drug Combination May Boost Weight Loss in Older Women, Study Finds
A retrospective study from Mayo Clinic and Wayne State University found that postmenopausal women combining tirzepatide with hormone therapy lost significantly more body weight than those using the drug alone, prompting calls for larger, controlled c
-
GLP-1 Users Often Restart Medication After Stopping, Finds Study; What Exactly Happens After Quitting?
The study found that a significant portion of patients who discontinued the drug actually went back to treatment within a year.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Scientists Cure Pancreatic Cancer In Mice Without Major Side Effects
Scientists achieved pancreatic cancer tumour disappearance in mice using a triple combination therapy, paving the way for future clinical trials.
-
Combined Drug Therapy Shows Promise Against Aggressive Childhood Brain Cancer: Study
A team of Australian researchers has tested a new way of treating childhood brain cancer by combining two medicines in lab studies.
-
Amid Cough Syrup Deaths, Auditor Flags Madhya Pradesh's Mega Purchase Of Banned Drugs
Even as Madhya Pradesh reels from the tragic deaths of 23 children in Chhindwara due to a toxic cough syrup, a new revelation from the Comptroller and Auditor General has exposed a deeper crisis in the state's drug regulation and procurement system.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Combining These Two Commonly Prescribed Drugs May Reverse Fatty Liver, Reveals Study
Pemafibrate and Telmisartan are medications primarily used to manage cholesterol and blood pressure, respectively. The study suggests that they may also be highly effective when used together to treat fatty liver disease.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Drug Combination May Boost Weight Loss in Older Women, Study Finds
A retrospective study from Mayo Clinic and Wayne State University found that postmenopausal women combining tirzepatide with hormone therapy lost significantly more body weight than those using the drug alone, prompting calls for larger, controlled c
-
GLP-1 Users Often Restart Medication After Stopping, Finds Study; What Exactly Happens After Quitting?
The study found that a significant portion of patients who discontinued the drug actually went back to treatment within a year.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Scientists Cure Pancreatic Cancer In Mice Without Major Side Effects
Scientists achieved pancreatic cancer tumour disappearance in mice using a triple combination therapy, paving the way for future clinical trials.
-
Combined Drug Therapy Shows Promise Against Aggressive Childhood Brain Cancer: Study
A team of Australian researchers has tested a new way of treating childhood brain cancer by combining two medicines in lab studies.
-
Amid Cough Syrup Deaths, Auditor Flags Madhya Pradesh's Mega Purchase Of Banned Drugs
Even as Madhya Pradesh reels from the tragic deaths of 23 children in Chhindwara due to a toxic cough syrup, a new revelation from the Comptroller and Auditor General has exposed a deeper crisis in the state's drug regulation and procurement system.
